Argentina

The Argentine pharmaceutical market was valued at US$2.4bn in 2006 and continues to expand steadily. Sales are expected to reach US$3.0bn in 2011. While the market has recovered from... 2007-06-06

German drugmaker Bayer-Schering, is to support the World Health Organisation (WHO) in its fight against Chagas disease by making 2.5mn tablets of antifungal Lampit (nifurtimox) available... 2007-04-12

US drugmaker Eli Lilly and local player HLB Pharma have announced investments in research and production in Argentina, in what is still, in BMI's view, one of the most difficult local... 2007-02-09

Argentine pharmaceutical group Laboratorios Richmond is planning to invest US$10mn in equipment and upgrades at a recently purchased facility to produce oncology and generic, bio-equivalent... 2007-01-09

The World Health Organisation (WHO) has warned that Latin America remains one of the regions worst affected by illegal medicines such as counterfeits. IMPACT - a new working group... 2006-11-20

Argentine pharmaceutical industry associations CAEME, CILFA and CPERALA have insisted that member companies have not significantly raised prices since the introduction of anti-inflation... 2006-11-14

Drugmakers in Argentina are entering new export markets as far afield as Yemen and Singapore, helping to reduce reliance on traditional markets in Latin America. The region still... 2006-11-09

State-owned agencies in Argentina plan to boost local production ofessential vaccines, but attempts to drive the project forward have stalleddue to bureaucratic problems. A roundtable... 2006-10-18

Argentina's government has unveiled ARS68mn (US$21.9mn) in added funding to wipe out Chagas disease. The condition is endemic to much of Latin America and kills an estimated 55,000... 2006-09-22

Latin American pharmaceutical group Tecnofarma is to expand its Zodiac unit in Brazil, spending some BRL12mn (US$5.6mn) on acquiring new brands in the oncology segment. The company... 2006-09-11